Highest-materiality recent filing
Lifeloc Q1 net loss narrows to $153K; SpinDetect mold milestone achieved
Net revenue $2.294M (+1% YoY), net loss $153K ($0.06/diluted share) vs $293K loss in Q1 2025.
Lifeloc Technologies enters $500K promissory note with CFO/Chairman for SpinDetect development
Principal $500K, 10.5% initial interest, interest-only payments through Dec 31, 2026.
Lifeloc FY 2025 revenue up 6% to $9.027M; net loss widens to $2.47M on deferred tax charge
Revenue $9.027M (+6% YoY); net loss $2.470M ($0.90/diluted share) vs $1.053M loss in 2024.
Lifeloc Technologies Reports Q3 2025 Revenue Up 8% but Net Loss Widens to $263K
Q3 2025 net revenue $2.257M, up 8% from $2.087M in Q3 2024, but net loss increased to $(263K) from $(158K).
Lifeloc Technologies acquires ELST via merger; exchange ratio 0.048
Each share of ELST common stock will be converted into 0.048 shares of Lifeloc common stock, plus cash for fractional shares.
Lifeloc to present at Emerging Growth Conference on Sep 25; CEO to discuss SpinDetect
CEO Dr. Wayne Willkomm to present at live virtual Emerging Growth Conference on September 25, 2025 at 2:20 PM ET.
Lifeloc Technologies enters into Amendment No. 3 to License Agreement with Sandia
On August 26, 2025, Lifeloc Technologies signed Amendment No. 3 to License Agreement 15-C02736 with National Technology & Engineering Solutions of Sandia, LLC.
Net revenue $2.219M, down 7% YoY; net loss $(394k) ($0.14 loss per share) vs $(298k) loss in Q2 2024.
Shareholders re-elect five directors and ratify Assure CPA as auditor for FY2025
All five director nominees elected with 2,136,243 votes for and 299 withheld each.
Lifeloc Q1 revenue up 6% to $2.28M, net loss $(293k) from $(284k) YoY
Q1 net revenue $2.277M (+6% YoY); net loss $(293k) or $(0.11) per diluted share.
Lifeloc reports FY2024 net loss of $1.05M on revenue down 8% to $8.54M
Net loss of $1.053M ($0.41 diluted EPS) vs net profit of $205.6K ($0.08 EPS) in 2023.
Lifeloc Technologies secures $750,000 subordinated debenture with 8.25% interest and warrants
Issued $750,000 subordinated debenture to Diamond Bridge Capital at 8.25% interest, maturing Dec 31, 2030; quarterly interest through 2025 then monthly P&I.
Lifeloc Q3 2024 net loss $158K, revenue down 23% YoY; SpinDx progress
Q3 net revenue $2.087M (down 23% YoY); net loss $158K ($0.06/diluted) vs prior year profit $110K.
Lifeloc Q2 2024 net loss of $298K; rev $2.387M (+5% YoY); SpinDx beta in 2024
Net loss $(298K) ($0.12/diluted) vs net income $55K ($0.02) in Q2 2023.
Lifeloc raises $798K via private placement, appoints new director, secures $750K credit line
Issued 210,000 shares at $3.80 to EDCO Partners, raising $798K; EDCO now holds 77.5% of common stock.
Lifeloc shareholders re-elect all five directors, ratify auditor at annual meeting
All five director nominees elected with 1,959,965 votes for and 2,329 withheld; no against votes.
Lifeloc Technologies dismisses GreenGrowth CPAs, engages Assure CPA as new auditor
Audit committee dismissed GreenGrowth CPAs on May 20, 2024; no disagreements or reportable events occurred.
Lifeloc Q1 net loss widens to $284K; revenue flat at $2.15M
Net revenue $2.153M flat YoY ($2.165M); net loss $(284)K ($0.12/diluted) vs $(54)K loss ($0.02/sh).
Lifeloc reports 2023 revenue $9.33M, net profit $206K vs loss prior year
Net revenue $9.330M (+10% YoY); net profit $206K ($0.08 diluted EPS) vs net loss $456K ($0.19 loss) in 2022.
On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.
On July 23, 2024, in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), the Board appointed Adam Kashenberg to fill the vacancy on the Board and on the Company’s audit committee created by Mr. Greenlee’s resignation.
Max materiality 0.75 · Median 0.60 · Most common event earnings